可药性
兴奋剂
药代动力学
体内
药效学
药理学
胰高血糖素样肽1受体
受体
医学
化学
内科学
生物
生物化学
遗传学
基因
作者
Jingchao Sun,Yao Xiao,Xing Wei,Wenjuan Jiang,Xuefeng Hu,Hongchao Li,Zhaojun Liu,Qian Jin,Peng Ren,Hongmei Zhang,Peter E Lobie
标识
DOI:10.1016/j.biopha.2024.116965
摘要
GLP-1 receptor agonists are clinically utilized for type 2 diabetes and obesity. In vitro and in vivo preclinical studies were performed to assess the druggability of a novel small molecule GLP-1 receptor biased agonist SAL0112.
科研通智能强力驱动
Strongly Powered by AbleSci AI